CD8A and type 1 diabetes mellitus: Our previous work showed that HLA‐A*2402‐restricted PPI‐specific CD8+ T cell clones derived from patients with type 1 diabetes are able to kill isolated β cells in vitro, exemplifying the potential for such cells to directly mediate β cell death in individuals with type 1 diabetes 88.